Medication-Assisted Treatment (MAT)
If you are struggling with addiction, MAT can help sustain recovery.
Medication-Assisted Treatment Explained
Medication-assisted treatment (MAT) is the use of medications, in combination with counseling and behavioral therapies, to provide “whole person-centered care”. We provide treatment for substance use disorders including opioid use disorder, alcohol use disorder as well as innovative approaches for management of methamphetamine, Cocaine and cannabis related disorders to reduce cravings and risk of harm.
Medications used in MAT are approved by the Food and Drug Administration (FDA) such as Buprenorphine/Naloxone (aka Suboxone) and Vivitrol if appropriate to patient care. We also incorporate the innovative use of FDA approved NSS-2 BRIDGE device system which can be used as an aid to reduce the symptoms of opiate withdrawal. Our MAT provider(s) create treatment plans tailored to meet each individual’s needs.
Research shows that a combination of medication and therapy can successfully treat these disorders, and for some people struggling with addiction, MAT can help sustain recovery. MAT is also used to prevent or reduce opioid overdose. As an integrated agency we can provide a combination of services at one location, helping to better serve you through coordinated care.
Mat-Su Health Services, Inc. prohibits discrimination in all of its programs and activities on the basis of race, color, national origin, age, disability, and where applicable, sex, marital status, familial status, parental status, religion, sexual orientation, political beliefs, genetic information, reprisal, or because all or part of an individual's income is derived from any public assistance program.
We receive federal funding through the Health Resources and Services Administration and are also known as a Federally Qualified Health Center (FQHC). Mat-Su Health Services primary care clinic is a Health Center Program grantee under 42 U.S.C. 254b, and a deemed Public Health Service employee under 42 U.S.C. 233(g)-(n).